Curcumin organogel for osteoarthritis treatment
- Conditions
- Osteoarthritis.Osteoarthritis of knee
- Registration Number
- IRCT20220531055045N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Having symptom of pain in joint Osteoarthritis (at Knee), stiffness, difficulty in flexion and extension, swelling for more than 3 months prior to the study
Being free of any systemic or dermatological diseases
Willing to refrain from using any lotion, gel, balm, moisturizer, cleanser, cosmetic or cream on the treatment areas during the treatment period
Being able to give written informed consent in a manner approved by the Institutional Ethics Committee and complying with the requirements of the study
Willing to avoid participation in any other interventional clinical trial during current study
No known allergy to Curcumin and plants of the ginger family
Showing a systemic or local allergic reaction to Curcumin organogel
Discontinuation of the treatment before end of intervention, or stopping it for at least three consecutive days
A decision to withdraw from the study
Death
Hospitalization
Moving to another city
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain, Stiffness, Difficulty in knee movement. Timepoint: Before, 1, 2, 4 and 8 weeks after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index.
- Secondary Outcome Measures
Name Time Method